PHAT R&D to Revenue
Phathom Pharmaceuticals Inc · R&D to Revenue
PHAT R&D to Revenue
Latest reported10.52%period ending
PHAT Quarterly R&D/Revenue (0.00% → 10.52%)
Latest values, visible window
High-resolution chart · PNG
PHAT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.5192% | |
| 13.3291% | |
| 13.0123% | |
| 14.1948% | |
| 22.9755% | |
| 32.2031% | |
| 28.9341% | |
| 53.1617% | |
| 100.71% | |
| 493.2008% | |
| 1,963.783% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |